Abstract
PET has become a cornerstone procedure in modern lymphoma management. This paper reviews, from a clinical point of view, the evidence for using PET in the different subtypes of lymphoma and the different steps of their management. The reader is given an overview of the current PET-based interventional lymphoma trials and an insight into possible future developments in the field, including new PET tracers.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Expert Review of Hematology |
| Vol/bind | 2 |
| Udgave nummer | 3 |
| Sider (fra-til) | 261-76 |
| Antal sider | 16 |
| ISSN | 1747-4086 |
| DOI | |
| Status | Udgivet - jun. 2009 |